Medincell (STU:MEB) Other Stockholders Equity : €-48.85 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Medincell Other Stockholders Equity?

Medincell's Other Stockholders Equity for the quarter that ended in Sep. 2023 was €-48.85 Mil.

Medincell's quarterly Other Stockholders Equity increased from Sep. 2022 (€-19.49 Mil) to Mar. 2023 (€-17.95 Mil) but then declined from Mar. 2023 (€-17.95 Mil) to Sep. 2023 (€-48.85 Mil).

Medincell's annual Other Stockholders Equity increased from Mar. 2021 (€-47.28 Mil) to Mar. 2022 (€4.27 Mil) but then declined from Mar. 2022 (€4.27 Mil) to Mar. 2023 (€-17.95 Mil).

Medincell Other Stockholders Equity Historical Data

The historical data trend for Medincell's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Other Stockholders Equity Chart

Medincell Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Stockholders Equity

Get a 7-Day Free Trial

-7.42

-25.43

-47.28

4.27

-17.95

Medincell Semi-Annual Data
	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Other Stockholders Equity	Get a 7-Day Free Trial										2.98	4.27	-19.49	-17.95	-48.85

Medincell Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Medincell Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Medincell's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell (STU:MEB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (STU:MEB) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

MEDCL:France MEB:Germany

Address

3 rue des Freres Lumiere, Jacou, FRA, 34830

Website

https://www.medincell.com

Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell (STU:MEB) Headlines

No Headlines